MYD88 p.(L265P) detection on cell‐free DNA in liquid biopsies of patients with primary central nervous system lymphoma
Open Access
- 8 November 2018
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 185 (5) , 974-977
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunitiesCritical Reviews in Oncology/Hematology, 2018
- The use of droplet digital PCR in liquid biopsies: A highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluidHematological Oncology, 2017
- Clinical significance of disease‐specific MYD88 mutations in circulating DNA in primary central nervous system lymphomaCancer Science, 2017
- Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphomaOncotarget, 2017
- Targetable genetic features of primary testicular and primary central nervous system lymphomasBlood, 2016
- Characteristics and outcome of patients with primary CNS lymphoma in a “real-life” setting compared to a clinical trialAnnals of Hematology, 2016
- Frameless image-guided stereotactic brain biopsies: emphasis on diagnostic yieldActa Neurochirurgica, 2014
- Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphomaActa Neuropathologica, 2011
- Identification of Leptomeningeal Disease in Aggressive B-Cell Non-Hodgkin's Lymphoma: Improved Sensitivity of Flow CytometryJournal of Clinical Oncology, 2009
- High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytologyBlood, 2005